PATENT CLAIM ANALYSIS

Application Number: 16019753
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["424", "231100"]

Abstract:
The invention relates to methods of treating melanoma using a herpes simplex virus in combination with an immune checkpoint inhibitor.

Claim (Index 4):
A kit comprising a herpes simplex virus lacking functional ICP34.5 genes, lacking a functional ICP47 gene and comprising a gene encoding human GM-CSF and a package insert or label with directions to treat stages IIIb to IV melanoma by using a combination of the herpes simplex virus and an immune checkpoint inhibitor.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 94.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14424424', '16068823', '16068816', '15748284', '16068826']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.717234033361568
- 35 USC 102 Novelty (BERT): 0.6139991861579694
- Combined Prediction Score: 0.7069105486412082
- Mean Citation Score: 328.87953
- Max Citation Score: 553.5156
- Similarity Product: 516.5655029457091

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test